Citywide Infectious Diseases Conference (September 24, 2025)

Needs Statement

Healthcare professionals need a stronger foundation in recognizing and treating common and uncommon infections. This includes the ability to interpret data and apply it to clinical decision-making. Additionally, there is a need for up-to-date knowledge of evolving treatment recommendations, especially in areas where resistance patterns are changing or where clinical data may be limited. Through interactive case discussions, this series aims to provide a platform for clinicians to discuss current treatment recommendations and equip learners with the ability to make informed choices about therapy based on diagnostic findings, patient-specific factors, and local practice considerations. Strengthening these competencies will support more effective, evidence-based care and improve patient outcomes across a range of clinical scenarios.

Educational Objectives

At the conclusion of the sessions, the participants should be able to:

• Recognize key clinical features and diagnostic indicators, including symptoms, laboratory markers, risk factors, and imaging findings, associated with a broad range of infectious diseases.
• Differentiate types of immune deficiencies and identify the infectious diseases commonly associated with each.
• Formulate a comprehensive differential diagnosis for patients presenting with infectious symptoms and select appropriate diagnostic tests based on clinical context, patient history, and current evidence.
• Apply evidence-based treatment strategies for infectious diseases, incorporating current clinical guidelines and patient-specific factors to optimize therapeutic outcomes.

Target Audience

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.